InvestorsHub Logo
Followers 89
Posts 6883
Boards Moderated 1
Alias Born 09/18/2009

Re: A deleted message

Tuesday, 03/19/2024 1:20:21 PM

Tuesday, March 19, 2024 1:20:21 PM

Post# of 43436
"I don't think there is any way in hell that Pfizer and Moderna will stay in the covid vaccine market past the end of the year, and run the risk of putting their mRNA vaccines into the market, without immunity from prosecution."

We'll see if that proves to be the case. It would definitely mean admitting defeat on the course that Pfizer, Moderna, and the FDA have been mandating.

And in the UK, I see what could be further recognition that the wrong covid treatment course was chosen. The UK announced that the fourth module of their national Covid-19 Inquiry will be rescheduled.

start at the beginning. this section of information concludes at the 4 minute mark, and goes on to an important discussion of 'Disease X.'


The Daily Mail, however, reported that the continued probe into the covid vaccines will be postponed indefinitely. So again, we'll see what proves to be the case. Maybe we'll even see mRNA abandoned by Pfizer, Moderna, and the FDA, in favor of traditional vaccines, like Nuvaxovid. Or maybe those companies will just abandon the covid market, which could by then be held by Humanigen/Novavax.

I'm tempted to start an additional post at this point, but I want to speak more about the video that you have open already. Continue watching at minute 4.

Our current failure stems from unauthorized gain-of-function research, conducted without utilizing the required bio-containment measures.

Research into Disease X also requires gain-of-function utilization, to possibly produce another novel coronavirus, which I think could be the Pangolin Coronavirus GX_P2V, as I'll feature in the following video.



You can start at minute mark 10:40, if you don't have 26 minutes to watch the whole video.

So, is this the reason the UK's Covid-19 Inquiry was basically put on hold, to begin preparations for the next biological threat?

I like Dr. John Campbell, who is not an MD, by the way. He has a PhD, and teaches clinical nursing. But I sure would like to see him discuss lenzilumab with Durrant and Dale. They are the world 's experts here, in my opinion, and they ought to spearhead, with other doctors (not government agents), where we go from here. It's imperative, when faced with a virus that has a 100% mortality rate, that the virus is denied access to targeted receptor cells.

"In patients diagnosed with covid pneumonia, and treated with lenzilumab, what is the recurrence rate of those patients presenting with SARS-CoV-2 nucleocapsid proteins after treatment?"
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.